- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
3
1 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
3 companies
Exelixis
Market Cap: US$11.6b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$44.21
7D
4.9%
1Y
23.0%
BioStem Technologies
Market Cap: US$68.8m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
New
BSEM
US$4.83
7D
28.8%
1Y
-64.2%
Earth Science Tech
Market Cap: US$39.5m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.17
7D
17.3%
1Y
13.3%